Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bimatoprost in Japanese patients with glaucoma or ocular hypertension
NCT00651859Phase 2Completed
- Sponsor
- Allergan
- Start
- Nov 2002
- Primary completion
- Jan 2004
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of bimatoprost in open-angle glaucoma (OAG) and ocular hypertension (3 arms), sponsored by Allergan. Primary endpoint: Intraocular pressure at Day 14. Started Nov 2002; status: completed.
02
Drugs
bimatoprost
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT00651859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00651859.